1273307-62-2

Upstream product

• 32315-10-9 bis(trichloromethyl) carbonate 
• 1273316-14-5 2-(2-methoxyethyl)-9-methyl-7,9-dihydro-8H-purine-8-one 
• 1273316-06-5 3-[4-(trifluoromethyl)phenyl]azetidine trifluoroacetate salt 
• 89283-49-8 2-chloro-4-(methylamino)-5-nitropyrimidine 
• 17587-95-0 2-chloro-N⁴-methylpyrimidine-4,5-diamine 
• 1273315-11-9 2-chloro-9-methyl-7H-purin-8(9H)-one 
• 1273315-66-4 2-chloro-9-methyl-7-{[2-(trimethylsilyl)ethoxy]methyl}-7,9-dihydro-8H-purine-8-one 
• 1273316-08-7 9-methyl-7-{[2-(trimethylsilyl)ethoxy]methyl}-2-[(trimethylsilyl)ethynyl]-7,9-dihydro-8H-purine-8-one 
• 1273316-10-1 2-[(Z)-2-methoxyethenyl]-9-methyl-7-{[2-(trimethylsilyl)ethoxy]methyl}-7,9-dihydro-8H-purine-8-one 
• 1273316-12-3 2-(2-methoxyethyl)-9-methyl-7-{[2-(trimethylsilyl)ethoxy]methyl}-7,9-dihydro-8H-purine-8-one 

Relevant academic research and scientific papers

8-OXODIHYDROPURINE DERIVATIVE

The present invention provides a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof (wherein W represents a hydrogen atom, a halogen atom, or the others; A represents an alkyl group optionally substituted by aryl group or the others, an aryl group, or the others; and one of X and Y represents a di-substituted alkylaminocarbonyl group, or the others, and the other represents a hydrogen atom, an alkyl group, an alkylcarbonyl group, or the others); a medicament or a pharmaceutical composition for treatment or prophylaxis of FAAH-related diseases such as depression, anxiety disorder or pains, comprising the compound or the like as an active ingredient; a use of the compound or the like; and a method for treatment or prophylaxis using the compound or the like.